The Viral Hemorrhagic Fever Consortium is a partnership of international research institutions investigating Ebola and Lassa. Our mission is to promote global health and safety by creating new products to diagnose, treat, and significantly reduce the incidence and mortality of viral hemorrhagic fevers.


Latest News & Publications

VHFC researchers describe predictors of Lassa fever outcome

A team of scientists at led by Pardis Sabeti at the Broad Institute has published a study that presents detailed clinical and laboratory data for Nigerian patients with Lassa fever. The authors did a multi-year large-scale retrospective, observational cohort study of...

Partner center CViSB launched with a $15 million grant from NIAID

With a new $15 million grant, VHFC scientists at The Scripps Research Institute (TSRI) are gearing up for an in-depth study of survivors of viral outbreaks. The grant from the National Institutes of Health’s National Institute of Allergy and Infectious...